par Rouamba, Toussaint 
;Sondo, Paul;Yerbanga, Isidore IW;Compaore, Adelaide;Traore-Coulibaly, Maminata;Hien, Franck FS;Diande, Nassirou NA;Valia, Daniel;Valea, Innocent;Akweongo, Patricia;Baiden, Rita;Binka, Fred;Kirakoya, Fati ;Tinto, Halidou
Référence Patient Preference and Adherence, 13, page (371-380)
Publication Publié, 2019-11-01
;Sondo, Paul;Yerbanga, Isidore IW;Compaore, Adelaide;Traore-Coulibaly, Maminata;Hien, Franck FS;Diande, Nassirou NA;Valia, Daniel;Valea, Innocent;Akweongo, Patricia;Baiden, Rita;Binka, Fred;Kirakoya, Fati ;Tinto, HalidouRéférence Patient Preference and Adherence, 13, page (371-380)
Publication Publié, 2019-11-01
Article révisé par les pairs
| Résumé : | In 2005, Burkina Faso changed its first-line treatment for uncomplicated malaria from chloroquine to artemisinin-based combination therapies (ACTs). Patient adherence to ACTs regimen is a keystone to achieve the expected therapeutic outcome and prevent the emergence and spread of parasite resistance. Eleven years after the introduction of ACTs in the health system, this study aimed to measure adherence level of patients in rural settlement and investigate the determinants of nonadherence. |
